Real-world evidence of a biosimilar to aflibercept: Evaluating the efficacy and safety of intravitreal aflibercept injection (Zhu Chuming) in diabetic macular edema (DME) and wet age-related macular degeneration (wAMD)

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 41260ef059223d8cd1dc77226dc54147fe8b9f78
First added on: Jan 24, 2026